When obtaining vital signs, a nursing assistive personnel is concerned that the heart rate of 56 is too low for a 23-year-old client who has been training for a marathon. The nurse explains that:
1. A low heart rate is normal in well-conditioned athletes
2. The health care provider needs to be notified immediately
3. The heart rate needs to be rechecked before taking any action
4. The heart rate could be caused by hyperthyroidism
ANS: 1
A heart rate lower then 60 is a normal response to sleep or in a well-conditioned athlete; dimin-ished blood flow to SA node, vagal stimulation, hypothyroidism, increased intracranial pressure, or pharmacological agents (e.g., digoxin, propranolol, quinidine, procainamide) sometimes cause abnormal drops in rate. Any action that the nurse is considering taking should occur only after verifying an abnormal vital sign.
You might also like to view...
A patient is diagnosed with renal insufficiency. The results of an ABG analysis indicate metabolic acidosis. In metabolic acidosis, the nurse would expect the pH to decrease to less than _____ and the bicarbonate level to decrease to less than _____
Fill in the blank(s) with correct word
Which of the following symptoms must the nurse consider when monitoring clients with cancer who are administered antineoplastic agents?
A) Symptoms of gout C) Symptoms of diarrhea B) Symptoms of hypertension D) Symptoms of anemia
A staff nurse has demonstrated the ability to be competent as a participant in surveillance and investigation activities. What skills would you expect that nurse to possess? Select all that apply
a. The ability to identify appropriate data sources b. The ability to communicate effectively using written reports c. The ability to collaborate with community agencies d. The ability to create a budget
Spironolactone produces its potassium-sparing diuretic effect by being an aldosterone receptor agonist that:
A. aldosterone receptor agonist that stimulates sodium and potassium exchange. B. aldosterone receptor antagonist that inhibits sodium and potassium exchange. C. aldosterone receptor antagonist that inhibits hydrogen and potassium exchange. D. aldosterone receptor agonist that stimulates hydrogen and potassium exchange.